70 East Beaver Creek Road
Unit 30
Richmond Hill, ON L4B 3B2
Canada
https://www.stagezerolifesciences.com
Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 40
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. James R. Howard-Tripp | Executive Chairman & CEO | 251,58k | N/D | N/D |
Dr. Choong-Chin Liew Ph.D. | Co-Founder | 68,22k | N/D | N/D |
Mr. Warren Whitehead C.M.A., CPA | Chief Accountant | N/D | N/D | 1952 |
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.
L'ISS Governance QualityScore di StageZero Life Sciences Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.